OpenAlex
PricingAboutJobs
Log inGet started
Work

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)

HTML

Year: 2017
Type: article
Source: Blood
DOI: 10.1182/blood-2017-03-771873
Authors: Fleur Cohen Aubart, Jean-François Emile, Fabrice Carrat, Frédéric Charlotte, Neila Benameur, Jean Donadieu, Philippe Maksud, Ahmed Idbaih, Stéphane Barete, Khê Hoang-Xuan, Zahir Amoura, Julien Haroche
Institutions: Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Université Pierre-et-Marie-Curie, Université de Versailles Saint-Quentin-en-Yvelines, Hôpital Ambroise-Paré, Inserm, Hôpital Saint-Antoine, Institut Pierre Louis d‘Épidémiologie et de Santé Publique, Hôpital Armand-Trousseau
Language: English

Topic: Histiocytic Disorders and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: Erdheim-Chester disease, targeted therapy, treatment interruption, follow-up, Langerhans cell histiocytosis
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2724414938
FWCI: 15.08
Cites: 14
Cited by: 221
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms